Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT. (Q53182763)

12 May 2018

title

Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT. (English)

1 reference

12 May 2018

1 reference

1 reference

8

1 reference

12 May 2018

author name string

Juha T Kauppi

1

1 reference

12 May 2018

Niku Oksala

2

1 reference

12 May 2018

Jarmo A Salo

3

1 reference

12 May 2018

Heikki Helin

4

1 reference

12 May 2018

Lauri Karhumäki

5

1 reference

12 May 2018

Jukka Kemppainen

6

1 reference

12 May 2018

Eero I Sihvo

7

1 reference

12 May 2018

publication date

2 January 2012

1 reference

12 May 2018

published in

Acta Oncologica

1 reference

12 May 2018

volume

51

1 reference

12 May 2018

issue

5

1 reference

12 May 2018

page(s)

636-644

1 reference

12 May 2018

Global cancer statistics, 2002

cites work

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.643822

Multimodality therapy for esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.643822

Fate of patients with adenocarcinoma of the esophagus and the esophagogastric junction: a population-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.643822

A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.643822

Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.643822

Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.643822

Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.643822

Adenocarcinoma of the esophagus and the esophagogastric junction: positron emission tomography improves staging and prediction of survival in distant but not in locoregional disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.643822

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.643822

[18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.643822

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.643822

Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.643822

Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.643822

Positron emission tomographic scanning predicts survival after induction chemotherapy for esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.643822

Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.643822

Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer: results of a prospective multi-center trial (SAKK 75/02).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.643822

Early repeated 18F-FDG PET scans during neoadjuvant chemoradiation fail to predict histopathologic response or survival benefit in adenocarcinoma of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.643822

Mean and maximum standardized uptake values in [18F]FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.643822

2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.643822

Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.643822

The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.643822

Effects of neoadjuvant radio-chemotherapy on 18F-FDG-PET in esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.643822

Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of 18F FDG PET: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.643822

Interval Between Neoadjuvant Chemoradiotherapy and Surgery for Squamous Cell Carcinoma of the Thoracic Esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.643822

10.3109/0284186X.2011.643822

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018